375 related articles for article (PubMed ID: 8805247)
21. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
Nattermann J; Nischalke HD; Hofmeister V; Ahlenstiel G; Zimmermann H; Leifeld L; Weiss EH; Sauerbruch T; Spengler U
Am J Pathol; 2005 Feb; 166(2):443-53. PubMed ID: 15681828
[TBL] [Abstract][Full Text] [Related]
22. Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
Zhang Q; Liu K; Yue C; Zhang D; Lu D; Xiao W; Liu P; Zhao Y; Gao G; Ding C; Lyu J; Liu WJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522857
[TBL] [Abstract][Full Text] [Related]
23. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
25. Antigen processing and presentation by human trophoblast-derived cell lines.
Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
[TBL] [Abstract][Full Text] [Related]
26. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
[TBL] [Abstract][Full Text] [Related]
27. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
28. The role of peptide presentation in the physiological function of HLA-G.
Münz C; Nickolaus P; Lammert E; Pascolo S; Stevanović S; Rammensee HG
Semin Cancer Biol; 1999 Feb; 9(1):47-54. PubMed ID: 10092550
[TBL] [Abstract][Full Text] [Related]
29. Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E.
Tzeng CM; Adams EJ; Gumperz JE; Percival L; Wells RS; Parham P; Barber LD
Tissue Antigens; 1996 Oct; 48(4 Pt 1):325-8. PubMed ID: 8946687
[TBL] [Abstract][Full Text] [Related]
30. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
Pietra G; Romagnani C; Moretta L; Mingari MC
Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
[TBL] [Abstract][Full Text] [Related]
31. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
32. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
[TBL] [Abstract][Full Text] [Related]
33. Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.
Ruibal P; Franken KLMC; van Meijgaarden KE; van Loon JJF; van der Steen D; Heemskerk MHM; Ottenhoff THM; Joosten SA
J Immunol; 2020 Nov; 205(10):2861-2872. PubMed ID: 33020145
[TBL] [Abstract][Full Text] [Related]
34. Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ
J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342
[TBL] [Abstract][Full Text] [Related]
35. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
Lampen MH; Hassan C; Sluijter M; Geluk A; Dijkman K; Tjon JM; de Ru AH; van der Burg SH; van Veelen PA; van Hall T
Mol Immunol; 2013 Jan; 53(1-2):126-31. PubMed ID: 22898188
[TBL] [Abstract][Full Text] [Related]
36. Rhesus macaque MHC class I molecules present HLA-B-like peptides.
Hickman-Miller HD; Bardet W; Gilb A; Luis AD; Jackson KW; Watkins DI; Hildebrand WH
J Immunol; 2005 Jul; 175(1):367-75. PubMed ID: 15972670
[TBL] [Abstract][Full Text] [Related]
37. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
[TBL] [Abstract][Full Text] [Related]
38. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
39. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
[TBL] [Abstract][Full Text] [Related]
40. HLA-G molecule.
Kamishikiryo J; Maenaka K
Curr Pharm Des; 2009; 15(28):3318-24. PubMed ID: 19860681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
